Publication | Closed Access

Vaccination with the Immediate-Early Protein ICP47 of Herpes Simplex Virus-Type 1 (HSV-1) Induces Virus-Specific Lymphoproliferation, but Fails to Protect against Lethal Challenge

VaccinationVaccine DevelopmentVaccine TargetImmunologyImmediate-early Protein Icp47PathologyVirologyHerpesvirusesAntiviral ResponseVirus-specific LymphoproliferationVaccine DesignMedicineVaccine ResearchLethal ChallengeHerpes Simplex Virus Vaccines